Photo by Wance Paleri on Unsplash

Extendicare Inc. with the ticker EXETF is a small-cap medical care facilities company operating in the healthcare business sector. This is the second of five healthcare candidates competing for the forty-ninth slot in my Viital folio. It is my first report on EXETF for my Viital portfolio, or for any of my previous six portfolios.

Extendicare Inc. is a long-term care facilities company. The business has five segments including Long-term care; Retirement living; Home health care; Other Canadian operations and Corporate segment.

The long-term care segment represents the long-term care homes operated by the company. The Retirement Living segment operates retirement communities that provide services to private-pay residents. The Home Health Care segment provides nursing care, physical therapy, and assisting services to accommodate individuals living at home.

The Other Canadian Operations segment provides consulting services to other care providers. The company generates a vast majority of its revenue from Canada.

Extendicare Inc. was founded in 1968 and is based in Markham, Canada.

Three key data points gauge any dividend equity or fund such as Extendicare Inc:

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether any company has made, is making, and will make money.
 

EXETF Price

Extendicare’s price per share was $5.58 as of yesterday’s market close.  One year ago it’s price was $6.40. So, EXETF’s share price fell by $0.82, or about 13% in the past year.

If Extendicare’s stock trades in the range of $5.00 to $6.50 this next year, its recent $5.58 share price might rise by $0.42 to reach $6.00 by next year. My $0.42 upside estimate is about $0.13  over the average annual price increase over the past fourteen years.
 

EXETF Dividends

Extendicare’s most recently declared a monthly dividend of $0.0308 is payable September 15th to shareholders on record as of August  30th.

Since October 2010 EXETF has paid monthly dividends, which have varied from $0.07 to $0.03 over the years. The current forward-looking annual dividend of $0.37 casts an annual yield 6.62% as of yesterday’s $5.58 share price.
 

EXETF Returns

Adding the $0.37 EXETF annual dividend to my estimated one-year price upside estimate of $0.42 shows a $0.79 potential gross gain, per share, to be reduced by any costs to trade EXETF shares.

At yesterday's $5.58 closing price, a little under $1000 would buy 179 shares.

A $10 broker fee (if charged) would be paid half at purchase and half at sale and might cost us $0.06 per share.

Subtract that maybe $0.06 brokerage cost from my estimated $0.79 gross gain estimate per share results in a net gain of $0.73 X 179 shares = $130.67 for a 13.00% net gain including a 6.62% forward looking annual dividend yield.

Over the next year our $1K investment in Extendicare Inc shares could generate $66.20 in cash dividends. Of course, a single share of EXETF stock bought at yesterday's $5.58 price is over 10 times less than the dividend income from our $1000.00 investment.

So, by my dogcatcher ideal, this is a positive time to acquire EXETF shares based on their forward looking dividends for the year 2022. The forecast annual dividend from $1K invested is 11.86  times greater than yesterday’s single share price. Consider yourself alerted. Now is the time.

All of the estimates above are speculation based on the past history of Extendicare Inc. Only time and money invested in this stock will determine its market value.

More By This Author:

Daily Stock Analysis: Walgreens Boots Alliance - Your Neighborhood Drugstore
Daily Stock Analysis: Union Bankshares
Daily Stock Analysis: Mercury General